Literature DB >> 25840105

Purification and functional characterization of mucosal IgA from vaccinated and SIV-infected rhesus macaques.

Thomas Musich1, Thorsten Demberg1, Ian L Morgan1, Jacob D Estes2, Genoveffa Franchini1, Marjorie Robert-Guroff3.   

Abstract

Vaccine-induced mucosal antibodies are often evaluated using small volumes of secretory fluids. However, fecal matter containing mucosal IgA is abundant. We purified fecal IgA from five SIV-vaccinated and five SIV-infected rhesus macaques by sequential affinity chromatography. The purified IgA was dimeric by native PAGE, contained secretory component, and was analogous to IgA in colostrum and vaginal fluid by western blot. IgA from one infected and four vaccinated animals neutralized H9-derived SIV(mac)251 with IC(50)s as low as 1 μg/mL. Purified IgAs inhibited transcytosis and exhibited phagocytic activity, the latter significantly correlated with SIV(mac)251 Env-specific IgA in the purified samples. Among different affinity resins, peptide M was optimal compared to jacalin, anti-monkey IgA and SSL7 for IgA purification, as confirmed using tandem peptide M/anti-monkey IgA columns. Fecal IgA provided material sufficient for several assays relevant to protective efficacy, and was shown to be multifunctional. Our approach is potentially applicable to human clinical studies. Published by Elsevier Inc.

Entities:  

Keywords:  Feces; Neutralization; Non-human primate mucosal IgA; Peptide M; Phagocytosis; Transcytosis inhibition

Mesh:

Substances:

Year:  2015        PMID: 25840105      PMCID: PMC4464970          DOI: 10.1016/j.clim.2015.03.020

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  55 in total

Review 1.  The role of secretory antibodies in infection immunity.

Authors:  Richard A Strugnell; Odilia L C Wijburg
Journal:  Nat Rev Microbiol       Date:  2010-08-09       Impact factor: 60.633

2.  Replicating adenovirus-simian immunodeficiency virus (SIV) recombinant priming and envelope protein boosting elicits localized, mucosal IgA immunity in rhesus macaques correlated with delayed acquisition following a repeated low-dose rectal SIV(mac251) challenge.

Authors:  Peng Xiao; L Jean Patterson; Seraphin Kuate; Egidio Brocca-Cofano; Michael A Thomas; David Venzon; Jun Zhao; Janet DiPasquale; Claudio Fenizia; Eun Mi Lee; Irene Kalisz; Vaniambadi S Kalyanaraman; Ranajit Pal; David Montefiori; Brandon F Keele; Marjorie Robert-Guroff
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

3.  Secretory IgA-Fcα receptor interaction modulating phagocytosis and microbicidal activity by phagocytes in human colostrum of diabetics.

Authors:  Eduardo Luzía França; Glilciane Morceli; Danny Laura Gomes Fagundes; Marilza Vieira Cunha Rudge; Iracema De Mattos Paranhos Calderon; Adenilda Cristina Honorio-França
Journal:  APMIS       Date:  2011-07-18       Impact factor: 3.205

4.  Robust antigen-specific humoral immune responses to sublingually delivered adenoviral vectors encoding HIV-1 Env: association with mucoadhesion and efficient penetration of the sublingual barrier.

Authors:  William Domm; Lauren Brooks; Hung Li Chung; Changyong Feng; William J Bowers; Gene Watson; James L McGrath; Stephen Dewhurst
Journal:  Vaccine       Date:  2011-07-27       Impact factor: 3.641

5.  A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples.

Authors:  Margaret E Ackerman; Brian Moldt; Richard T Wyatt; Anne-Sophie Dugast; Elizabeth McAndrew; Stephen Tsoukas; Stephanie Jost; Christoph T Berger; Gaia Sciaranghella; Qingquan Liu; Darrell J Irvine; Dennis R Burton; Galit Alter
Journal:  J Immunol Methods       Date:  2010-12-27       Impact factor: 2.303

6.  Immunization with HIV-1 gp41 subunit virosomes induces mucosal antibodies protecting nonhuman primates against vaginal SHIV challenges.

Authors:  Morgane Bomsel; Daniela Tudor; Anne-Sophie Drillet; Annette Alfsen; Yonatan Ganor; Marie-Gaëlle Roger; Nicolas Mouz; Mario Amacker; Anick Chalifour; Lorenzo Diomede; Gilles Devillier; Zhe Cong; Qiang Wei; Hong Gao; Chuan Qin; Gui-Bo Yang; Rinaldo Zurbriggen; Lucia Lopalco; Sylvain Fleury
Journal:  Immunity       Date:  2011-02-25       Impact factor: 31.745

7.  SIVmac239 MVA vaccine with and without a DNA prime, similar prevention of infection by a repeated dose SIVsmE660 challenge despite different immune responses.

Authors:  Lilin Lai; Sue-Fen Kwa; Pamela A Kozlowski; David C Montefiori; Tracy L Nolen; Michael G Hudgens; Welkin E Johnson; Guido Ferrari; Vanessa M Hirsch; Barbara K Felber; George N Pavlakis; Patricia L Earl; Bernard Moss; Rama Rao Amara; Harriet L Robinson
Journal:  Vaccine       Date:  2011-12-15       Impact factor: 3.641

8.  The gp41 epitope, QARVLAVERY, is highly conserved and a potent inducer of IgA that neutralizes HIV-1 and inhibits viral transcytosis.

Authors:  S Jain; K L Rosenthal
Journal:  Mucosal Immunol       Date:  2011-04-27       Impact factor: 7.313

9.  Nasal DNA-MVA SIV vaccination provides more significant protection from progression to AIDS than a similar intramuscular vaccination.

Authors:  M Manrique; P A Kozlowski; S-W Wang; R L Wilson; E Micewicz; D C Montefiori; K G Mansfield; A Carville; A Aldovini
Journal:  Mucosal Immunol       Date:  2009-09-09       Impact factor: 7.313

Review 10.  Acute HIV-1 Infection.

Authors:  Myron S Cohen; George M Shaw; Andrew J McMichael; Barton F Haynes
Journal:  N Engl J Med       Date:  2011-05-19       Impact factor: 91.245

View more
  5 in total

Review 1.  Recombinant IgA production for mucosal passive immunization, advancing beyond the hurdles.

Authors:  Vikram Virdi; Paloma Juarez; Veronique Boudolf; Ann Depicker
Journal:  Cell Mol Life Sci       Date:  2015-10-28       Impact factor: 9.261

2.  Impact of IgG Isotype on the Induction of Antibody-Dependent Cellular Phagocytosis of HIV by Human Milk Leukocytes.

Authors:  Alisa Fox; Xiaomei Liu; Susan Zolla-Pazner; Rebecca L Powell
Journal:  Front Immunol       Date:  2022-05-03       Impact factor: 8.786

3.  Similar Epitope Specificities of IgG and IgA Antibodies Elicited by Ad26 Vector Prime, Env Protein Boost Immunizations in Rhesus Monkeys.

Authors:  Zi Han Kang; Christine A Bricault; Erica N Borducchi; Kathryn E Stephenson; Michael S Seaman; Maria Pau; Hanneke Schuitemaker; Danielle van Manen; Frank Wegmann; Dan H Barouch
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

4.  Vaccine with bacterium-like particles displaying HIV-1 gp120 trimer elicits specific mucosal responses and neutralizing antibodies in rhesus macaques.

Authors:  Huaiyu Wang; Pingchao Li; Mo Zhang; Jinpeng Bi; Yizi He; Fangshen Li; Rongzhen Yu; Feng Gao; Wei Kong; Bin Yu; Ling Chen; Xianghui Yu
Journal:  Microb Biotechnol       Date:  2022-03-15       Impact factor: 6.575

Review 5.  Challenges in mucosal HIV vaccine development: lessons from non-human primate models.

Authors:  Iskra Tuero; Marjorie Robert-Guroff
Journal:  Viruses       Date:  2014-08-15       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.